Miyagami M, Kagawa Y, Tsubokawa T
No Shinkei Geka. 1985 Sep;13(9):955-63.
Drug delivery to the tumor has been one of the major subjects in the field of brain tumor chemotherapy because of blood brain barrier. Recent studies including quantitative autoradiographic studies revealed that blood brain barrier is present and intact in the brain adjacent to tumor where viable tumor cells are infiltrating, and also in the tumors which are early in the development. In 1972 Rapoport et al demonstrated that it is possible to transiently and reversibly open the blood brain barrier by an intracarotid infusion of a hyperosmoral solution. This technique is found to increase cerebrovascular permeability to chemotherapeutic agents. Six cases of glioma, including 4 astrocytoma grade 4, 1 astrocytoma grade 3, 1 astrocytoma grade 2, were treated during operation with intracarotid infusion of ACNU 100 mg/body/5 min. (1.3-2.2 mg/kg) following intracarotid infusion of 20% mannitol 200 ml (1.3-1.6 ml/sec) through the catheter in the internal carotid artery set preoperatively, and ACNU concentration in tumor tissues and blood were measured at 5, 10, 15, 20, 25, 30, 40, 60 minutes after that. On every case mannitol contrast enhancement CT was studied by the intracarotid infusion of 60% conray 100 ml/5 min. following the intracarotid infusion of 20% mannitol 200 ml comparing with contrast enhancement CT and plain CT. Maximum ACNU concentrations in blood were 2.12-4.12 micrograms/ml (mean 3.1 +/- 0.74) at 5 min. after the intraarterial administration of mannitol and ACNU on every case. At 20 min. following the administration ACNU levels were decreased to half level (mean 1.49 +/- 0.42 microgram/ml) and 0.58 +/- 0.18 microgram/ml at 60 min.(ABSTRACT TRUNCATED AT 250 WORDS)
由于血脑屏障的存在,肿瘤的药物递送一直是脑肿瘤化疗领域的主要课题之一。包括定量放射自显影研究在内的近期研究表明,在肿瘤邻近区域有存活肿瘤细胞浸润且血脑屏障完整,在肿瘤早期阶段也是如此。1972年,拉波波特等人证明通过颈内动脉输注高渗溶液可以短暂且可逆地打开血脑屏障。该技术被发现可增加脑血管对化疗药物的通透性。6例胶质瘤患者,包括4例4级星形细胞瘤、1例3级星形细胞瘤、1例2级星形细胞瘤,在手术期间通过术前置于颈内动脉的导管先输注20%甘露醇200毫升(1.3 - 1.6毫升/秒),随后在5分钟内颈内动脉输注ACNU 100毫克/体(1.3 - 2.2毫克/千克),并在之后的5、10、15、20、25、30、40、60分钟测量肿瘤组织和血液中的ACNU浓度。对每例患者在颈内动脉输注20%甘露醇200毫升后,通过颈内动脉输注60%泛影葡胺100毫升/5分钟进行甘露醇对比增强CT研究,并与对比增强CT和平扫CT进行比较。在每例患者动脉内给予甘露醇和ACNU后5分钟,血液中ACNU的最大浓度为2.12 - 4.12微克/毫升(平均3.1±0.74)。给药后20分钟,ACNU水平降至一半(平均1.49±0.42微克/毫升),60分钟时为0.58±0.18微克/毫升。(摘要截取自250字)